June 24–26, 2027, Rome, Italy

Keynote Speaker

Thomas Bernd Dschietzig

TBThomas Bernd Dschietzig, Relaxera GmbH & Co. KG
Keynote

Thomas Bernd Dschietzig

Relaxera GmbH & Co. KG

Germany

About Thomas Bernd Dschietzig

Thomas Bernd Dschietzig studied Medicine at Charité, the Medical Faculty of the Humboldt University of Berlin, Germany, and is a specialist of Internal Medicine focused on cardiovascular research. His lab and clinical work have been focused on the study of physiology and pathophysiology of the naturally occurring peptide hormone human relaxin-2. He is Chief Executive Officer and co-founder of Relaxera, a pharma company dedicated to develop synthetic human relaxin-2 for chronic clinical use in cardio-vascular disease, especially in Heart Failure with Preserved Ejection Fraction, HFpEF.

1 Previous Presentation

Past editions

Join the Heart Congress 2027 delegation

Rome · June 24–26, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us